Published in J Virol on August 17, 2011
Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J Virol (2012) 1.64
Reassortment events among swine influenza A viruses in China: implications for the origin of the 2009 influenza pandemic. J Virol (2011) 1.19
Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China. J Virol (2011) 1.09
Virulence and transmissibility of H1N2 influenza virus in ferrets imply the continuing threat of triple-reassortant swine viruses. Proc Natl Acad Sci U S A (2012) 1.08
Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China. J Virol (2014) 0.97
Insights into the increasing virulence of the swine-origin pandemic H1N1/2009 influenza virus. Sci Rep (2013) 0.90
The global antigenic diversity of swine influenza A viruses. Elife (2016) 0.90
Human infection with Eurasian avian-like influenza A(H1N1) virus, China. Emerg Infect Dis (2013) 0.88
North American triple reassortant and Eurasian H1N1 swine influenza viruses do not readily reassort to generate a 2009 pandemic H1N1-like virus. MBio (2014) 0.88
In vivo selection of H1N2 influenza virus reassortants in the ferret model. J Virol (2013) 0.85
Epidemic status of Swine influenza virus in china. Indian J Microbiol (2013) 0.84
Reliability of a newly-developed immunochromatography diagnostic kit for pandemic influenza A/H1N1pdm virus: implications for drug administration. PLoS One (2012) 0.83
Emergence of H3N2pM-like and novel reassortant H3N1 swine viruses possessing segments derived from the A (H1N1)pdm09 influenza virus, Korea. Influenza Other Respir Viruses (2013) 0.81
Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice. Influenza Other Respir Viruses (2013) 0.80
In vitro reassortment between endemic H1N2 and 2009 H1N1 pandemic swine influenza viruses generates attenuated viruses. PLoS One (2012) 0.79
The 2009 pandemic (H1N1) viruses isolated from pigs show enhanced pathogenicity in mice. Vet Res (2013) 0.79
Transmission dynamics of pandemic influenza A(H1N1)pdm09 virus in humans and swine in backyard farms in Tumbes, Peru. Influenza Other Respir Viruses (2016) 0.79
Efficient isolation of Swine influenza viruses by age-targeted specimen collection. J Clin Microbiol (2015) 0.77
Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin. Virol J (2012) 0.76
Infectivity and Transmissibility of Avian H9N2 Influenza Viruses in Pigs. J Virol (2016) 0.76
Experimental infection with a Thai reassortant swine influenza virus of pandemic H1N1 origin induced disease. Virol J (2013) 0.76
Genomic reassortants of pandemic A (H1N1) 2009 virus and endemic porcine H1 and H3 viruses in swine in Japan. J Vet Med Sci (2014) 0.75
Phylogenetic diversity and genotypic complexity of H1N1 subtype swine influenza viruses isolated in mainland China. Virol J (2012) 0.75
Pandemic Seasonal H1N1 Reassortants Recovered from Patient Material Display a Phenotype Similar to That of the Seasonal Parent. J Virol (2016) 0.75
Transmission and pathogenicity of novel reassortants derived from Eurasian avian-like and 2009 pandemic H1N1 influenza viruses in mice and guinea pigs. Sci Rep (2016) 0.75
Sus scrofa miR-204 and miR-4331 Negatively Regulate Swine H1N1/2009 Influenza A Virus Replication by Targeting Viral HA and NS, Respectively. Int J Mol Sci (2017) 0.75
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
Cases of swine influenza in humans: a review of the literature. Clin Infect Dis (2007) 6.56
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology (1985) 5.65
Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science (2010) 4.92
The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol (2000) 4.65
The emergence of novel swine influenza viruses in North America. Virus Res (2002) 4.41
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ (1981) 4.20
Persistence of Hong Kong influenza virus variants in pigs. Science (1977) 2.72
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology (1994) 2.21
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol (2001) 2.15
Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One (2010) 2.04
Novel H1N2 swine influenza reassortant strain in pigs derived from the pandemic H1N1/2009 virus. Vet Microbiol (2010) 1.88
Reassorted pandemic (H1N1) 2009 influenza A virus discovered from pigs in Germany. J Gen Virol (2011) 1.83
Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd. J Virol (2009) 1.76
The role of swine in the generation of novel influenza viruses. Zoonoses Public Health (2009) 1.74
Pandemic (H1N1) 2009 outbreak on pig farm, Argentina. Emerg Infect Dis (2010) 1.74
The emergence of pandemic influenza viruses. Protein Cell (2010) 1.52
Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology (2010) 1.32
Human infection by a swine influenza A (H1N1) virus in Switzerland. Arch Virol (2003) 1.29
Human case of swine influenza A (H1N1), Aragon, Spain, November 2008. Euro Surveill (2009) 1.26
Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respir Viruses (2010) 1.21
Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986. Lancet (1986) 0.86
2009 pandemic H1N1 influenza virus replicates in human lung tissues. J Infect Dis (2010) 0.81
Pathogenicity and transmissibility of the pandemic H1N1 2009-related influenza viruses in mice, ferrets, and pigs. Influenza Other Respir Viruses (2011) 0.81
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet (2013) 10.66
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA (2009) 7.61
Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol (2005) 7.36
Are we ready for pandemic influenza? Science (2003) 7.20
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial. JAMA (2006) 6.34
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet (2004) 5.32
Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol (2004) 5.17
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol (2004) 5.08
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02
Influenza A viruses of migrating wild aquatic birds in North America. Vector Borne Zoonotic Dis (2004) 4.89
Molecular gas in the host galaxy of a quasar at redshift z = 6.42. Nature (2003) 4.54
Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine (2002) 4.45
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis (2013) 4.28
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA (2010) 4.21
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol (2009) 4.10
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem (2003) 4.03
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol (2007) 3.79
Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem (2005) 3.75
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A (2009) 3.70
Gain-of-function experiments on H7N9. Science (2013) 3.67
Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis (2003) 3.66
MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
H5N1 outbreaks and enzootic influenza. Emerg Infect Dis (2006) 3.49
Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis (2010) 3.49
A magneto-inductive sensor based wireless tongue-computer interface. IEEE Trans Neural Syst Rehabil Eng (2008) 3.38
Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerg Infect Dis (2013) 3.35
Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis (2006) 3.28
The influenza virus gene pool in a poultry market in South central china. Virology (2003) 3.25
Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect (2012) 3.22
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet (2012) 3.14
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14
Influenza-associated hospitalization in a subtropical city. PLoS Med (2006) 3.07
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother (2005) 3.04
Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg Infect Dis (2006) 2.98
Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol (2002) 2.97
Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog (2007) 2.94
Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86
Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong. J Infect Dis (2007) 2.82
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol (2007) 2.77
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis (2005) 2.72
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A (2007) 2.63
Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol (2002) 2.63
The rice tapetum degeneration retardation gene is required for tapetum degradation and anther development. Plant Cell (2006) 2.62
Evaluation of external RNA controls for the assessment of microarray performance. Nat Biotechnol (2006) 2.59
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J Clin Microbiol (2003) 2.55
Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol (2010) 2.55
H3N2 influenza virus transmission from swine to turkeys, United States. Emerg Infect Dis (2004) 2.53
Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med (2007) 2.53
The influenza virus enigma. Cell (2009) 2.48
MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis (2014) 2.47
Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis (2013) 2.47
Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res (2007) 2.45
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol (2005) 2.44
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis (2005) 2.43
Persistent host markers in pandemic and H5N1 influenza viruses. J Virol (2007) 2.42